喜树碱
拓扑异构酶
拓扑替康
DNA
结合位点
化学
立体化学
生物化学
劈理(地质)
插层(化学)
碱基对
酶
生物物理学
生物
遗传学
古生物学
化疗
无机化学
断裂(地质)
作者
Bart L. Staker,Kathryn A. Hjerrild,Michael D. Feese,Craig A. Behnke,Alex B. Burgin,Lance J. Stewart
标识
DOI:10.1073/pnas.242259599
摘要
We report the x-ray crystal structure of human topoisomerase I covalently joined to double-stranded DNA and bound to the clinically approved anticancer agent Topotecan. Topotecan mimics a DNA base pair and binds at the site of DNA cleavage by intercalating between the upstream (-1) and downstream (+1) base pairs. Intercalation displaces the downstream DNA, thus preventing religation of the cleaved strand. By specifically binding to the enzyme-substrate complex, Topotecan acts as an uncompetitive inhibitor. The structure can explain several of the known structure-activity relationships of the camptothecin family of anticancer drugs and suggests that there are at least two classes of mutations that can produce a drug-resistant enzyme. The first class includes changes to residues that contribute to direct interactions with the drug, whereas a second class would alter interactions with the DNA and thereby destabilize the drug-binding site.
科研通智能强力驱动
Strongly Powered by AbleSci AI